Related Experiment Videos
[Evidence based comparative analysis for managing osteoporosis in a primary health care setting]
Eunate Arana-Arri1, Iñaki Gutiérrez-Ibarluzea, María Luisa Gutiérrez Ibarzabal
1Servicio de Urgencias Generales, Hospital de Cruces, Baracaldo, Vizcaya, España. eunatea@telefonica.net
Objective:
To find out how physicians are managing osteoporosis in a primary care setting.
Design:
Cross-sectional study.
Context:
Primary care setting with a target population of 276,000 inhabitants, grouped into 9 basic health areas, Spain.
Participants:
Women older than 45 years old on treatments for osteoporosis.
Interventions:
Standardised questionnaire self-filled in by women and compared with clinical records.
Main Measurements:
Suitability of the indication of diagnostic tests, proportion of treatments supported by diagnostic tests and according to evidence.
Results:
The mean age of the sample was 65.3 (9.6) years. Of the women included, 73.2% (n=243) had an indication for densitometry and only 60.2% (n=200) of them had this performed. The results of the densitometries were: 14% (n=28) normal, 31% (n=62) osteopenia and 55% (n=110) osteoporosis. Based on risk factors, in those women with densitometry indication, 39.5% (n=96) did not have it performed. In those women with no risk factors to justify the indication of densitometry (n=89), 59.6% (n=53) did have it performed. The two-year follow densitometry was not carried out on 78.7% (n=261) of women. Statistically significant differences were observed in the percentages of adequacy of the indications of densitometry and in the percentages of adequacy of the treatments in the different medical specialities analyzed (P < .05). Of the women who had densitometry, 42.4% (n=81) were inadequately treated.
Conclusions:
The indication of densitometry is clearly improvable and there is a high variability in its adequacy in all the medical specialities studied. To a great extent, the indication of treatments for osteoporosis is not based on densitometry and is against the recommendations of the evidence based studies recently published.
Related Concept Videos
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.